CClinicalTrials.gg
Status unknownNCT00729014Updated Aug 6, 2008

A Study of Drug-Induced Kidney Disease

An observational study in End Stage Renal Disease, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2008-08-06.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified May 2008), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Retrospective
Enrollment
2,000
Sex
All
01

Study summary

The purpose of this study is to identify incidence of Chinese herb nephropathy in a medical center

Read the detailed description

This is a retrospective study, by computer screening, chart review and phone survey to find herbal nephropathy and determine the cause-relationship.

Using ICD-9-CM code as a tool to screen the newly diagnosed ESRD in NTUH computer data base, and divided patients into those with underlying disease(s) that cause the renal failure and those without.

02

Conditions studied

  • End Stage Renal Disease

Keywords

  • herbal nephropathy
  • Chinese herbal nephropathy
  • nephrotoxicity
  • renal disease
  • adverse drug reaction
  • Chinese herbal medicine
03

In context

Kidney Diseases

3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 192 across 1,033 observational studies indexed under Kidney Diseases.

Browse Kidney Diseases studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

a medical center

Inclusion criteria

  • patient who was newly diagnosed as end stage renal disease who need dialysis

Exclusion criteria

Exclusion Criteria:

  • started dialysis before 2000
05

Study design

Time perspective
Retrospective
Enrollment
2,000 participants (estimated)
06

What researchers measure

Primary outcomes

  1. The incidence of herbal nephropathy

    Time frame: 5 years

Secondary outcomes

  1. The epidemiology of primary diagnosis for end stage renal disease in Taiwan

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
    • Fe-Lin L. Wu, MSCP,Ph D · Contact · flwu@ntu.edu.tw · +886-2-23123456
    • Kwan-Dun Wu, MD, PhD · Contact · kdwu@ntuh.gov.tw · +886-2-23123456
    • Fe-Lin L. Wu, Ph D · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00729014
Lead sponsor
National Taiwan University Hospital
Collaborators
Department of Health, Executive Yuan, R.O.C. (Taiwan)
First posted
Aug 6, 2008
Start date
May 2008
Primary completion
Sep 2008 (estimated)
Last update
Aug 6, 2008

Study contacts

Fe-Lin L Wu, MSCP, Ph.D
Contact
flwu@ntu.edu.tw
886-2-23123456 ext. 8389
Kwan-Dun Wu, MD, Ph.D
Contact
kdwu@ntuh.gov.tw
886-2-23123456 ext. 5014
Kwan-Dun Wu, MD, PhD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion